Literature DB >> 12875905

Genetic analysis of Nurr1 haplotypes in Parkinson's disease.

Eng-King Tan1, Henry Chung, Yi Zhao, Hui Shen, V R Chandran, Chris Tan, Mei-lin Teoh, Yuan Yih, Ratnagopal Pavanni, Meng-Cheong Wong.   

Abstract

Nurr1 gene plays an important role in the development of the mesencephalic dopaminergic system. Genetic variability of Nurr1 gene may be associated with risk of Parkinson's disease (PD). We found three polymorphic loci (c.-2922(C)2-3, IVS6+18insG and EX8+657 (9-10CA)) of the Nurr1 gene in our PD patients and a novel intron 7+33 C-->T variant in one PD patient. We proceeded to perform a haplotype analysis in a case control study. A total of 202 PD patients (mean age 65.04+/-9.44 years, 55.4% men) and 202 age, gender and race matched controls (mean age 64.33+/-10.12 years, 54.0% men) were studied. The intron 7+33 C-->T variant was present in only one of the PD patients (0.5%) but in none of the controls. The Nurr1 mRNA levels in the lymphocytes did not significantly differ between the affected patient and controls. We found complete linkage disequilibrium between c.-2922(C)2-3 and IVS6+18insG polymorphic loci (D=0.25). Analysis of the three loci haplotype frequencies did not demonstrate any significant difference between PD and controls. There were also no significant differences in the haplotype frequencies between young and late onset PD patients. In conclusion, we demonstrated a large common haplotype block spanning the Nurr1 gene in our population. The intron 7+33 C-->T variant most likely represents either a non-functional mutation or a rare polymorphism in our study population. Our study suggests that Nurr1 variability is unlikely to play a major role in the majority of our PD patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875905     DOI: 10.1016/s0304-3940(03)00539-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  NURR1 in Parkinson disease--from pathogenesis to therapeutic potential.

Authors:  Mickael Decressac; Nikolaos Volakakis; Anders Björklund; Thomas Perlmann
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

Review 2.  Pathological proteins in Parkinson's disease: focus on the proteasome.

Authors:  Heather Snyder; Benjamin Wolozin
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 3.  Transcription Factors: Potential Cell Death Markers in Parkinson's Disease.

Authors:  Ronglin Wang; Shaosong Yang; Tiejian Nie; Gang Zhu; Dayun Feng; Qian Yang
Journal:  Neurosci Bull       Date:  2017-08-08       Impact factor: 5.203

4.  Nur(R1)turing a notion on the etiopathogenesis of Parkinson's disease.

Authors:  Howard J Federoff
Journal:  Neurotox Res       Date:  2009-04-24       Impact factor: 3.911

5.  A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C).

Authors:  Gaynor A Smith; Emily M Rocha; Thomas Rooney; Pascal Barneoud; Jesse R McLean; Jonathan Beagan; Teresia Osborn; Madeleine Coimbra; Yongyi Luo; Penelope J Hallett; Ole Isacson
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

6.  Efficient and biologically relevant consensus strategy for Parkinson's disease gene prioritization.

Authors:  Maykel Cruz-Monteagudo; Fernanda Borges; Cesar Paz-Y-Miño; M Natália D S Cordeiro; Irene Rebelo; Yunierkis Perez-Castillo; Aliuska Morales Helguera; Aminael Sánchez-Rodríguez; Eduardo Tejera
Journal:  BMC Med Genomics       Date:  2016-03-09       Impact factor: 3.063

7.  Identification of NURR1 (Exon 4) and FOXA1 (Exon 3) Haplotypes Associated with mRNA Expression Levels in Peripheral Blood Lymphocytes of Parkinson's Patients in Small Indian Population.

Authors:  Jayakrishna Tippabathani; Jayshree Nellore; Vaishnavie Radhakrishnan; Somashree Banik; Sonia Kapoor
Journal:  Parkinsons Dis       Date:  2017-01-31

8.  Failure of Glial Cell-Line Derived Neurotrophic Factor (GDNF) in Clinical Trials Orchestrated By Reduced NR4A2 (NURR1) Transcription Factor in Parkinson's Disease. A Systematic Review.

Authors:  Piniel Alphayo Kambey; Kouminin Kanwore; Abiola Abdulrahman Ayanlaja; Iqra Nadeem; YinZhen Du; Wokuheleza Buberwa; WenYa Liu; Dianshuai Gao
Journal:  Front Aging Neurosci       Date:  2021-02-24       Impact factor: 5.750

9.  Molecular characterization and analysis of the porcine NURR1 gene.

Authors:  Knud Larsen; Jamal Momeni; Leila Farajzadeh; Henrik Callesen; Christian Bendixen
Journal:  Biochim Open       Date:  2016-07-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.